|  Help  |  About  |  Contact Us

Publication : ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex.

First Author  Li Z Year  2007
Journal  Cancer Cell Volume  12
Issue  6 Pages  542-58
PubMed ID  18068631 Mgi Jnum  J:130323
Mgi Id  MGI:3771481 Doi  10.1016/j.ccr.2007.11.012
Citation  Li Z, et al. (2007) ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. Cancer Cell 12(6):542-58
abstractText  To better understand the cellular origin of breast cancer, we developed a mouse model that recapitulates expression of the ETV6-NTRK3 (EN) fusion oncoprotein, the product of the t(12;15)(p13;q25) translocation characteristic of human secretory breast carcinoma. Activation of EN expression in mammary tissues by Wap-Cre leads to fully penetrant, multifocal malignant breast cancer with short latency. We provide genetic evidence that, in nulliparous Wap-Cre;EN females, committed alveolar bipotent or CD61(+) luminal progenitors are targets of tumorigenesis. Furthermore, EN transforms these otherwise transient progenitors through activation of the AP1 complex. Given the increasing relevance of chromosomal translocations in epithelial cancers, such mice serve as a paradigm for the study of their genetic pathogenesis and cellular origins, and generation of preclinical models.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

20 Bio Entities

Trail: Publication

0 Expression